南宫NG·28(中国)相信品牌力量

Rio de Janeiro, Brazil—Recently, Shanghai MicroPort Endovascular MedTech (Group) Co., Ltd. (“Endovastec™”), debuted at the XVI Pan American Congress on Vascular and Endovascular Surgery (PAN 2021) with two flagship products, the Castor™Branched Aortic Stent-Graft System (“Castor™ Stent”) and the Minos™ Abdominal Aortic Stent-Graft and Delivery System (“Minos™ Stent Graft System”). As the most prestigious and authoritative congress for endovascular surgery in Latin America, the online congress was attended by about 40 experts to discuss various hot topics related to aortic aneurysm, aortic arch, aortoiliac occlusive disease, subinguinal and distal venous thrombosis, COVID-19 complications, varicose vein surgery, and carotid artery surgery, among others.

Professor Chang Shu, Director of the Vascular Surgery Center at Fuwai Hospital of Chinese Academy of Medical Sciences shared his insights on "Using TEVAR technology for aortic aneurysm with a challenging proximal neck", a hot topic in the field of endovascular intervention. In his presentation, Prof. Chang shared the results and cases of a clinical study on Castor™. “The Castor™ stent is the world’s first stent-graft system for simultaneous aorta and aortic arch repair through minimally invasive treatment. Its unique unibody structure can not only adapt to a variety of arch anatomies, but also provide a creative solution to the problems of access and positioning of unibody branched stent-grafts, thereby supporting the convenient reconstruction of the left subclavian artery while avoiding gutter endoleaks that could be caused by the chimney technique or long-term stability risks resulting from the window technique. It also reduces the risk of stent migration in the long term,” he commented.

In addition, the Minos™ system was also presented at the conference to showcase its three-piece design which enables flexible assembly to accommodate different size requirements. Its main body was constructed from a laser-cut M-stent with integrated barbs and covered with seamless woven graft, and its iliac limbs are woven by a single wire in a spiraling pattern. The advanced core technologies are able to meet the treatment needs of a wider range of abdominal aortic aneurysms with complex anatomy, which reduces the rate of complications such as device migration, endoleaks, or occlusion, and thus lower the risk of long-term reintervention.

Castor™ and Minos™ have won the recognition of experts and demonstrated excellent performance in clinical applications in many countries across Europe and South America. As it continues to make its products available in new markets, Endovastec™ will also continue to strengthen in-depth collaboration with international clinical specialists, share clinical experiences and actively participate in academic conferences at home and abroad to promote academic exchange on aortic diseases, so that more medical solutions from China can benefit a greater number of patients and doctors worldwide.